Trial intelligence / Profile preview

FluEMIST: Flu Vaccine in Egg-allergic Patients

NCT01248208Phase 2Completed

Sponsor
Walter Reed Army Medical Center
Start
Sep 2010
Primary completion
Sep 2011
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 2 trial of influenza vaccine (trivalent, inactivated) or influenza vaccine (live, attenuated, intranasal) in influenza, sponsored by Walter Reed Army Medical Center. Started Sep 2010; status: completed.

02

Drugs

influenza vaccine (trivalent, inactivated) or influenza vaccine (live, attenuated, intranasal)
03

Conditions

influenza

Beyond the preview

Go deeper on NCT01248208.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01248208.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call